Evidence map›Paper›PMID 38054302›Full record

ArticleEmerging microbes & infections2024

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines.

Teresa Aydillo, Maria Balsera-Manzanero, Amaya Rojo-Fernandez, Alba Escalera, Celia Salamanca-Rivera, Jerónimo Pachón, María Del Mar Muñoz-García, María José Sánchez-Cordero, Javier Sánchez-Céspedes, Adolfo García-Sastre and 1 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Teresa AydilloDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID 0000-0003-3086-1058
Maria Balsera-ManzaneroViral Diseases and Infections in Immunodeficiencies Research Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
Amaya Rojo-FernandezDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Alba EscaleraDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Celia Salamanca-RiveraUnit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Sevilla, Spain.
Jerónimo PachónViral Diseases and Infections in Immunodeficiencies Research Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
María Del Mar Muñoz-GarcíaHealth Care Center Los Bermejales, Primary Care District, Andalusian Health Service, Seville.
María José Sánchez-CorderoHealth Care Center Los Bermejales, Primary Care District, Andalusian Health Service, Seville.
Javier Sánchez-CéspedesViral Diseases and Infections in Immunodeficiencies Research Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.ORCID 0000-0003-2707-1979
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Elisa CorderoViral Diseases and Infections in Immunodeficiencies Research Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.ORCID 0000-0001-7766-7266
Icahn School of Medicine at Mount Sinai · USAndalusian Health Service · ESInstituto de Biomedicina de Sevilla · ESInstituto de Salud Carlos III · ESCancer Institute (WIA) · INHospital Universitario Virgen del Rocío · ES

Funding

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH75N93019C00051 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAMMER, FLORIAN · 2019 to 2025
$105.4M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
NIAID NIH HHS 75N93019C00051NIAID NIH HHS 75N93021C00014
6 · The paper itself

Abstract

Current clinical guidelines support the concomitant administration of seasonal influenza vaccines and COVID-19 mRNA boosters vaccine. Whether dual vaccination may impact vaccine immunogenicity due to an interference between influenza or SARS-CoV-2 antigens is unknown. We aimed to understand the impact of mRNA COVID-19 vaccines administered concomitantly on the immune response to influenza vaccines. For this, 128 volunteers were vaccinated during the 22-23 influenza season. Three groups of vaccination were assembled: FLU vaccine only (46, 35%)

Indexed as

COVID-19COVID-19 VaccinesInfluenza, HumanInfluenza VaccinesAntibodies, ViralHumansInfluenza A Virus, H3N2 SubtypemRNA VaccinesSeasonsVaccinationAntibodies, ViralCOVID-19 VaccinesInfluenza VaccinesmRNA VaccinesCOVID-19influenzamRNA vaccineseasonal vaccinationVaccination

Identifiers

PMID38054302
PMCPMC10798284
OpenAlexW4389397749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.